Look for any podcast host, guest or anyone
Showing episodes and shows of

Ian Pavord

Shows

ON AIR with EUFOREAON AIR with EUFOREAEpisode #5: Reflections on the European Biologics Training Course 2024This podcast was recorded at the 1st edition of EUFOREA's European Biologics Training Course that took place on 1 March 2024 in Brussels, with special guests Prof. Peter Hellings (EUFOREA Founder and Chairman) and Prof. Ian Pavord (EUFOREA Asthma Expert Panel Member).2024-03-1308 minTreatable Traits & AsthmaTreatable Traits & AsthmaRisk Factors and Treatable TraitsHow do you identify the risk factors of your Asthma patients? And what is the MOST important treatable trait amongst these risks? Hear what professor Ian Pavord, Peter Gibson and Vibeke Backer thinks.🎙 The 4th episode of our new podcast series tunes in on exactly this. Listen now!2023-11-2327 minTreatable Traits & AsthmaTreatable Traits & AsthmaTreatable Traits in GeneralListen to Professor Peter Gibson, Professor Ian Pavord and Professor Vibeke Backer discussing why treatable traits in asthma is important.MAT-DK-2200672, v1, oct 20232023-10-1315 minGarden PeopleGarden PeopleGarden People: Sarah Statham - floral artist, Simply by ArrangementToday I welcome floral artist and flower friend and mentor, Sarah Statham of Simply by Arrangement. Whether writing from her corner of Yorkshire, England, or gardens farther afield, she is forever seeking light and the perfect pebble, and always celebrating color, form, and seasonality. Her role as an educator extends beyond the vase, providing invaluable business advice through one to one conversations with numerous flower fettlers, both seasoned and new. As much as I rely on her rock steady advice, it is her humor, love of learning, and keen sense of observation that I admire...2022-06-3049 minPulmonary MedicinePulmonary MedicineInvestigating T2 Inflammation in Severe Asthma & COPD Host: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Ian Pavord, MA, DM, FRCP, FERS, FMedSci Guest: Geoffrey Chupp, MD Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord from the University of Oxford. This is a nonpromotional, non-CME disease state educational podcast brought to you by the American College of CHEST Physicians in collaboration with and...2022-03-3100 minDeep Breaths: Updates from CHESTDeep Breaths: Updates from CHESTInvestigating T2 Inflammation in Severe Asthma & COPD Host: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Ian Pavord, MA, DM, FRCP, FERS, FMedSci Guest: Geoffrey Chupp, MD Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord from the University of Oxford. This is a nonpromotional, non-CME disease state educational podcast brought to you by the American College of CHEST Physicians in collaboration with and...2022-03-3100 minCritical CareCritical CareInvestigating T2 Inflammation in Severe Asthma & COPD Host: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Ian Pavord, MA, DM, FRCP, FERS, FMedSci Guest: Geoffrey Chupp, MD Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord from the University of Oxford. This is a nonpromotional, non-CME disease state educational podcast brought to you by the American College of CHEST Physicians in collaboration with and...2022-03-3100 minPulmonary MedicinePulmonary MedicineInvestigating T2 Inflammation in Severe Asthma & COPD Host: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Ian Pavord, MA, DM, FRCP, FERS, FMedSci Guest: Geoffrey Chupp, MD Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord from the University of Oxford. This is a nonpromotional, non-CME disease state educational podcast brought to you by the American College of CHEST Physicians in collaboration with and...2022-03-3100 minGeneral Medicine and Primary CareGeneral Medicine and Primary CareInvestigating T2 Inflammation in Severe Asthma & COPD Host: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Ian Pavord, MA, DM, FRCP, FERS, FMedSci Guest: Geoffrey Chupp, MD Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord from the University of Oxford. This is a nonpromotional, non-CME disease state educational podcast brought to you by the American College of CHEST Physicians in collaboration with and...2022-03-3100 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastIan Pavord, FMedSci - Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate to Severe AsthmaGo online to PeerView.com/DWM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in pulmonology discusses the latest clinical research and treatment guidelines on approved biologic therapies for the management of adult and pediatric patients with uncontrolled moderate to severe asthma. Upon completion of this accredited CE activity, participants should be better able to: Explain to peers the latest developments in clinical research and treatment guidelines with regard to the use of currently approved targeted therapy for the management of adult and pediatric patients with uncontrolled...2021-10-1334 minPeerView Immunology & Transplantation CME/CNE/CPE Video PodcastPeerView Immunology & Transplantation CME/CNE/CPE Video PodcastIan Pavord, FMedSci - Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate to Severe AsthmaGo online to PeerView.com/DWM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in pulmonology discusses the latest clinical research and treatment guidelines on approved biologic therapies for the management of adult and pediatric patients with uncontrolled moderate to severe asthma. Upon completion of this accredited CE activity, participants should be better able to: Explain to peers the latest developments in clinical research and treatment guidelines with regard to the use of currently approved targeted therapy for the management of adult and pediatric patients with uncontrolled...2021-10-1334 minPeerView Immunology & Transplantation CME/CNE/CPE Audio PodcastPeerView Immunology & Transplantation CME/CNE/CPE Audio PodcastIan Pavord, FMedSci - Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate to Severe AsthmaGo online to PeerView.com/DWM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in pulmonology discusses the latest clinical research and treatment guidelines on approved biologic therapies for the management of adult and pediatric patients with uncontrolled moderate to severe asthma. Upon completion of this accredited CE activity, participants should be better able to: Explain to peers the latest developments in clinical research and treatment guidelines with regard to the use of currently approved targeted therapy for the management of adult and pediatric patients with uncontrolled...2021-10-1334 minPeerView Clinical Pharmacology CME/CNE/CPE VideoPeerView Clinical Pharmacology CME/CNE/CPE VideoIan Pavord, FMedSci - Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate to Severe AsthmaGo online to PeerView.com/DWM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in pulmonology discusses the latest clinical research and treatment guidelines on approved biologic therapies for the management of adult and pediatric patients with uncontrolled moderate to severe asthma. Upon completion of this accredited CE activity, participants should be better able to: Explain to peers the latest developments in clinical research and treatment guidelines with regard to the use of currently approved targeted therapy for the management of adult and pediatric patients with uncontrolled...2021-10-1334 minPeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastPeerView Heart, Lung & Blood CME/CNE/CPE Audio PodcastIan Pavord, FMedSci - Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate to Severe AsthmaGo online to PeerView.com/DWM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in pulmonology discusses the latest clinical research and treatment guidelines on approved biologic therapies for the management of adult and pediatric patients with uncontrolled moderate to severe asthma. Upon completion of this accredited CE activity, participants should be better able to: Explain to peers the latest developments in clinical research and treatment guidelines with regard to the use of currently approved targeted therapy for the management of adult and pediatric patients with uncontrolled...2021-10-1334 minPeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastPeerView Heart, Lung & Blood CME/CNE/CPE Video PodcastIan Pavord, FMedSci - Across the Age Spectrum: Expert Insights on Emerging Uses of Targeted Therapy for the Treatment of Uncontrolled Moderate to Severe AsthmaGo online to PeerView.com/DWM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in pulmonology discusses the latest clinical research and treatment guidelines on approved biologic therapies for the management of adult and pediatric patients with uncontrolled moderate to severe asthma. Upon completion of this accredited CE activity, participants should be better able to: Explain to peers the latest developments in clinical research and treatment guidelines with regard to the use of currently approved targeted therapy for the management of adult and pediatric patients with uncontrolled...2021-10-1334 minHCPLive PodcastsHCPLive PodcastsBiologics for Inflammatory Care, COVID-19 ResearchDr. Ian Pavord discusses new meta-analyses of dupilumab planned for ATS 2020.2020-05-1825 minCHEST Journal PodcastsCHEST Journal PodcastsWithdraw inhaled corticosteroids in GOLD3 COPD patients?James D. Chalmers, MD, PhD, and Ian D. Pavord, FMedSci, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to debate if inhaled corticosteroids should be withdrawn in patients with in GOLD 3 COPD. 2018-04-0459 minInside HealthInside HealthCare.data, Asthma, Acne rosacea, PacemakersCare.data, the scheme to build an enormous database containing the medical records of all English patients has been scrapped. Dr Mark Porter investigates the fall-out following the cancellation of this expensive programme, which foundered on concerns about confidentiality and public and professional trust. Chair of the national EMIS user group and Sheffield GP Dr Geoff Schrecker and GP Dr Margaret McCartney discuss the scale of the failure of the care.data programme and outline what needs to happen in the future if valuable patient data is to be used for the public good.Twelve hundred adults...2016-07-1228 minTranslational and ClinicalTranslational and ClinicalAsthmaAirway inflammation Ian Pavord is Professor of Respiratory Medicine and has been joint Chief Medical Advisor to Asthma UK since May 2008. He has developed new techniques to get a better idea about airway inflammation and uses this information to investigate the best treatments to prevent asthma attacks.2014-12-107h 05Translational MedicineTranslational MedicineAsthmaAirway inflammation Ian Pavord is Professor of Respiratory Medicine and has been joint Chief Medical Advisor to Asthma UK since May 2008. He has developed new techniques to get a better idea about airway inflammation and uses this information to investigate the best treatments to prevent asthma attacks.2014-10-077h 05Translational MedicineTranslational MedicineAsthmaAirway inflammation Ian Pavord is Professor of Respiratory Medicine and has been joint Chief Medical Advisor to Asthma UK since May 2008. He has developed new techniques to get a better idea about airway inflammation and uses this information to investigate the best treatments to prevent asthma attacks.2014-10-077h 05Thorax podcastThorax podcastThe genomic origins of asthmaIan Pavord talks to Scott Weiss, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, about his review on the genomic origins of asthma, which considers several areas where environmental exposures, genomics, development and asthma occurrence overlap. Read the full review: http://goo.gl/KctouZ2014-07-0814 minThorax podcastThorax podcastThe genomic origins of asthmaIan Pavord talks to Scott Weiss, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, about his review on the genomic origins of asthma, which considers several areas where environmental exposures, genomics, development and asthma occurrence overlap. Read the full review: http://goo.gl/KctouZ2014-07-0814 minThorax PodcastThorax PodcastThe genomic origins of asthmaIan Pavord talks to Scott Weiss, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, about his review on the genomic origins of asthma, which considers several areas where environmental exposures, genomics, development and asthma occurrence overlap. Read the full review: http://goo.gl/KctouZ 2014-07-0814 minThorax podcastThorax podcastNon-eosinophilic asthmaIan Pavord (Thorax editor) talks to Peter Gibson (professor of respiratory medicine, John Hunter Hospital, New South Wales, Australia) about non-eosinophilic asthma, particularly neutrophilic asthma.They discuss the stability of the different inflammatory phenotypes, tools to recognise non-eosinophilic asthma, whether these patients benefit from inhaled steroids, and Professor Gibson’s paper investigating the relationship between H influenzae respiratory infection and neutrophilic asthma.See also:Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma2013-02-1323 minThorax podcastThorax podcastNon-eosinophilic asthmaIan Pavord (Thorax editor) talks to Peter Gibson (professor of respiratory medicine, John Hunter Hospital, New South Wales, Australia) about non-eosinophilic asthma, particularly neutrophilic asthma. They discuss the stability of the different inflammatory phenotypes, tools to recognise non-eosinophilic asthma, whether these patients benefit from inhaled steroids, and Professor Gibson’s paper investigating the relationship between H influenzae respiratory infection and neutrophilic asthma. See also: Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma2013-02-1323 minThorax PodcastThorax PodcastNon-eosinophilic asthmaIan Pavord (Thorax editor) talks to Peter Gibson (professor of respiratory medicine, John Hunter Hospital, New South Wales, Australia) about non-eosinophilic asthma, particularly neutrophilic asthma. They discuss the stability of the different inflammatory phenotypes, tools to recognise non-eosinophilic asthma, whether these patients benefit from inhaled steroids, and Professor Gibson’s paper investigating the relationship between H influenzae respiratory infection and neutrophilic asthma. See also: Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma 2013-02-1323 min